Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001
- PMID: 12396929
- PMCID: PMC2730315
- DOI: 10.3201/eid0810.020331
Adherence to antimicrobial inhalational anthrax prophylaxis among postal workers, Washington, D.C., 2001
Abstract
In October 2001, two envelopes containing Bacillus anthracis spores were processed at the Washington, D.C., Processing and Distribution Center of the U.S. Postal Service; inhalational anthrax developed in four workers at this facility. More than 2,000 workers were advised to complete 60 days of postexposure prophylaxis to prevent inhalational anthrax. Interventions to promote adherence were carried out to support workers, and qualitative information was collected to evaluate our interventions. A quantitative survey was administered to a convenience sample of workers to assess factors influencing adherence. No anthrax infections developed in any workers involved in the interventions or interviews. Of 245 workers, 98 (40%) reported full adherence to prophylaxis, and 45 (18%) had completely discontinued it. Anxiety and experiencing adverse effects to prophylaxis, as well as being <45 years old were risk factors for discontinuing prophylaxis. Interventions, especially frequent visits by public health staff, proved effective in supporting adherence.
Similar articles
-
Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.Emerg Infect Dis. 2002 Oct;8(10):1133-7. doi: 10.3201/eid0810.020346. Emerg Infect Dis. 2002. PMID: 12396928 Free PMC article.
-
Inhalational anthrax outbreak among postal workers, Washington, D.C., 2001.Emerg Infect Dis. 2002 Oct;8(10):1066-72. doi: 10.3201/eid0810.020330. Emerg Infect Dis. 2002. PMID: 12396917 Free PMC article.
-
Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence.Emerg Infect Dis. 2002 Oct;8(10):1124-32. doi: 10.3201/eid0810.020349. Emerg Infect Dis. 2002. PMID: 12396927 Free PMC article.
-
The prophylaxis and treatment of anthrax.Int J Antimicrob Agents. 2002 Nov;20(5):320-5. doi: 10.1016/s0924-8579(02)00200-5. Int J Antimicrob Agents. 2002. PMID: 12431866 Review.
-
Inhalational anthrax.J Thorac Imaging. 2006 Nov;21(4):252-8. doi: 10.1097/01.rti.0000213570.71161.84. J Thorac Imaging. 2006. PMID: 17110848 Review.
Cited by
-
Assessing parents' perception of children's risk for recreational water illnesses.Emerg Infect Dis. 2005 May;11(5):670-6. doi: 10.3201/eid1105.040779. Emerg Infect Dis. 2005. PMID: 15890117 Free PMC article.
-
Systemic but not mucosal immunity induced by AVA prevents inhalational anthrax.Microbes Infect. 2007 Oct;9(12-13):1478-83. doi: 10.1016/j.micinf.2007.08.002. Epub 2007 Aug 10. Microbes Infect. 2007. PMID: 17913545 Free PMC article.
-
Emergency response to an anthrax attack.Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):4346-51. doi: 10.1073/pnas.0636861100. Epub 2003 Mar 21. Proc Natl Acad Sci U S A. 2003. PMID: 12651951 Free PMC article.
-
Randomized, Controlled, Crossover trial of Prevention of Clindamycin-Induced Gastrointestinal Signs Using a Synbiotic in Healthy Research Cats.J Vet Intern Med. 2017 Sep;31(5):1406-1413. doi: 10.1111/jvim.14795. Epub 2017 Jul 29. J Vet Intern Med. 2017. PMID: 28755457 Free PMC article. Clinical Trial.
-
Public health in the time of bioterrorism.Emerg Infect Dis. 2002 Oct;8(10):1015-8. doi: 10.3201/eid0810.020444. Emerg Infect Dis. 2002. PMID: 12396908 Free PMC article. No abstract available.
References
-
- Friedlander A, Welkos S, Pitt M, Ezzell J, Worsham P, Rose K, et al. Postexposure prophylaxis against experimental inhalation anthrax. J Infect Dis. 1993;167:1239–42. - PubMed
-
- Sumartojo E. When tuberculosis treatment fails: a social behavioral account of patient adherence. Am Rev Respir Dis. 1993;147:1311–20. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical